Search

Your search keyword '"Bellefqih, Sara"' showing total 23 results
Start Over Author "Bellefqih, Sara"
23 results on '"Bellefqih, Sara"'

1. Influence of age and self-stigmatization on social eating and drinking issues in French outpatients living with and beyond head and neck cancer: a mixed-method study

Author

Beauplet, Bérengère, Francois, Bianca, Bastit, Vianney, Lequesne, Justine, Rambeau, Audrey, Basti, Samira, Gery, Bernard, Larnaudie, Audrey, Lasne-Cardon, Audrey, Roussel, Lise-Marie, Veresezan, Ovidiu, Jean, Clément Petit, Chatelier, Anne, Ambroise, Beatrice, Veyssiere, Alexis, Bellefqih, Sara, Thureau, Sébastien, Levitchi, Mihai, Obongo-Anga, Franchel Raïs, Babin, Emmanuel, Dornan, Mark, Mange, Jessica, and Humbert, Maxime

Published
2024
Full Text
View/download PDF

11. Prognostic factors in patients with soft palate squamous cell carcinoma

Author

Schernberg, Antoine, primary, Canova, Charles, additional, Blanchard, Pierre, additional, Gorphe, Philippe, additional, Breuskin, Ingrid, additional, Mirghani, Haitham, additional, Moya‐Plana, Antoine, additional, Janot, François, additional, Bidault, Francois, additional, Chargari, Cyrus, additional, Bellefqih, Sara, additional, Ruffier, Amandine, additional, Even, Caroline, additional, Nguyen, France, additional, Temam, Stéphane, additional, and Tao, Yungan, additional

Published
2019
Full Text
View/download PDF

14. Toxicity of concomitant cetuximab and radiotherapy with or without initial taxane-based induction chemotherapy in locally advanced head and neck cancer

Author

Levy, Antonin, DE FELICE, Francesca, Bellefqih, Sara, Guigay, Joël, Deutsch, Eric, Nguyen, France, Blanchard, Pierre, and Tao, Yungan

Subjects
Adult, Aged, 80 and over, Male, Mucositis, otorhinolaryngology, toxicity, Cetuximab, Chemoradiotherapy, Induction Chemotherapy, Exanthema, Middle Aged, pathology and forensic medicine, Head and Neck Neoplasms, Carcinoma, Squamous Cell, Humans, Female, Taxoids, Radiodermatitis, Deglutition Disorders, cetuximab, chemoradiotherapy, induction chemotherapy, Aged
Abstract

The purpose of this study was to evaluate the tolerability of concurrent radiotherapy and cetuximab (bioradiotherapy [BRT]) after taxane-based induction chemotherapy in head and neck squamous cell carcinoma (HNSCC).One hundred four patients with HNSCC received BRT with (29%) or without (71%) prior taxane-based induction chemotherapy.Radiodermatitis (97%) and skin rash (65%) occurred frequently, but there was no difference of occurrence or the grade of the rash observed in the 2 populations. However, patients receiving taxane-based induction chemotherapy had a less severe rash as compared with patients without induction chemotherapy. Mucositis and dysphagia were frequent and comparable in the 2 groups. The occurrence of a skin rash (at any grade) did not predict an increased overall survival (OS) in the overall population, but it was associated with an improved 3-year OS in patients receiving taxane-based induction chemotherapy. OS was not influenced by the skin rash grade in the overall population of the 2 treatment subgroups.Taxane-based induction chemotherapy did not increase the rate of cetuximab-related toxicities. © 2015 Wiley Periodicals, Inc. Head Neck 38: E905-E910, 2016.

Published
2015

15. Prognostic factors in patients with soft palate squamous cell carcinoma.

Author

Canova, Charles, Bellefqih, Sara, Ruffier, Amandine, Nguyen, France, Schernberg, Antoine, Tao, Yungan, Chargari, Cyrus, Blanchard, Pierre, Gorphe, Philippe, Breuskin, Ingrid, Mirghani, Haitham, Moya‐Plana, Antoine, Janot, François, Bidault, Francois, Even, Caroline, and Temam, Stéphane

Subjects
SOFT palate, SQUAMOUS cell carcinoma, PROGRESSION-free survival, UNIVARIATE analysis, THERAPEUTICS
Abstract

Background: To define the prognostic factors associated with outcome in patients with soft palate squamous cell carcinoma (SCC). Methods: Previously untreated patients with soft palate and uvula SCC treated in our institution between 1997 and 2012 were collected. The prognostic value of clinical, hematological, and treatment characteristics was examined. Results: We identified 156 patients, median age 58 years, with 71% drinkers, 91% smokers; 19% had synchronous cancer. Front‐line treatment was chemoradiotherapy in 58 (37%), radiotherapy alone in 60 (39%), surgery in 17 (11%), and induction chemotherapy in 21 patients (14%). The 5‐year actuarial overall survival (OS) and progression‐free survival (PFS) were 41% and 37%, respectively. In univariate analysis, T3‐T4 vs T1‐T2 stage, N2‐N3 vs N0‐N1 stage, and neutrophil count >7 g/L were associated with worse OS and PFS (P < .05). Conclusion: In patients with soft palate SCC, inflammation biomarkers were associated with OS. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

18. Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas

Author

Levy, Antonin, primary, Blanchard, Pierre, additional, Bellefqih, Sara, additional, Brahimi, Nacéra, additional, Guigay, Joël, additional, Janot, François, additional, Temam, Stéphane, additional, Daly-Schveitzer, Nicolas, additional, Bourhis, Jean, additional, and Tao, Yungan, additional

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results